Cholera Vibrio (Vibrio cholerae)

Vibrio cholerae is a Gram-negative, comma-shaped, motile bacterium that causes cholera. It spreads via the fecal-oral route, primarily through contaminated water and food, and poses serious public health challenges under inadequate sanitation conditions. Naturally present in aquatic ecosystems, V. cholerae is notable for its environmental reservoirs and pathogenic properties.

Vibrio cholerae is a Gram-negative, comma-shaped bacterium belonging to the family Vibrionaceae. It is motile due to a single polar flagellum, which facilitates its spread in both environmental and host conditions. The bacterium is facultatively anaerobic and can multiply in both oxygen-rich and oxygen-poor environments. It exhibits halophilic characteristics, thriving optimally in saline environments such as seawater while also surviving at low salt concentrations.

The bacterium is oxidase positive and ferments sugars such as glucose to produce acid. For laboratory identification, Thiosulfate-Citrate-Bile Salts-Sucrose (TCBS) agar is used; on this medium, V. cholerae forms yellow colonies due to sucrose fermentation. Serological classification is based on O antigens, with over 200 serogroups identified. However, only O1 and O139 serogroups are associated with cholera. The O1 serogroup is divided into Classical and El Tor biotypes; El Tor, with its greater environmental resilience and transmission capacity, is the primary agent of the seventh pandemic. The O139 serogroup emerged in India in 1992 and has been responsible for limited outbreaks.

^{Laboratory Microbiological Sample Examination (Generated with AI Support)}

V. cholerae has a bipartite genome consisting of two chromosomes: a large chromosome (approximately 3 Mb) and a small chromosome (approximately 1 Mb). Pathogenicity is linked to the CTXφ bacteriophage, which carries the cholera toxin (CT) genes. This bacteriophage transfers the toxin genes (ctxAB) to the bacterium via horizontal gene transfer. Additionally, toxin-coregulated pilus (TCP) genes, located within pathogenicity islands, enable the bacterium to adhere to the intestinal mucosa. Biofilm formation is regulated by vps (Vibrio polysaccharide synthesis) genes, which control the production of polysaccharide matrices and enhance the bacterium’s resistance to environmental stresses.

Vibrio cholerae is found in aquatic ecosystems such as seawater, river estuaries, lagoons, and freshwater lakes. It forms a symbiotic relationship with plankton, particularly copepods. It attaches to the chitinous surfaces of copepods and forms biofilms that protect it from environmental stresses such as UV radiation, salinity fluctuations, and nutrient scarcity. The vps genes play a critical role in biofilm matrix formation and support the bacterium’s long-term survival in environmental reservoirs.

The bacterium can enter a viable but non-culturable (VBNC) state, in which it remains metabolically active but cannot be cultured under standard laboratory conditions. The VBNC state enhances the persistence of V. cholerae in environmental reservoirs and complicates outbreak prediction.

Fish and shellfish are important environmental hosts of V. cholerae. The bacterium can colonize their intestines or surfaces. Consumption of raw or undercooked seafood increases the risk of human transmission. In coastal regions, cases of cholera have been linked to the consumption of contaminated seafood.

Water temperature, salinity, pH, and organic matter concentration influence the multiplication of V. cholerae. Warm, nutrient-rich waters provide ideal conditions for bacterial growth. Climate change, through rising sea surface temperatures and increased frequency of extreme weather events, can facilitate the spread of V. cholerae. For example, monsoon rains and floods accelerate the contamination of water sources with the bacterium.

Cholera toxin is the primary virulence factor of V. cholerae and is responsible for the hallmark symptoms of cholera. CT is an AB5-type enterotoxin composed of one A subunit and five B subunits. The B subunits bind to GM1 ganglioside receptors on intestinal epithelial cells, enabling the A subunit to enter the cell. The A subunit activates adenylate cyclase, increasing intracellular cyclic AMP (cAMP) levels. This triggers the secretion of chloride ions and water into the intestinal lumen, resulting in profuse, rice-water-like diarrhea.

ctxAB genes are carried by the CTXφ bacteriophage and enable the spread of toxin production among pathogenic strains. Toxin production is a process regulated by environmental signals and host factors.

TCP is a virulence factor that enables V. cholerae to adhere to the intestinal mucosa. TCP genes are located within a pathogenicity island and are co-regulated under environmental conditions. TCP supports bacterial colonization and biofilm formation, thereby enhancing the infection process.

Biofilm formation enhances the survival of V. cholerae both in environmental reservoirs and within the host. The vps genes regulate the synthesis of extracellular polysaccharides, the primary components of the biofilm matrix. Biofilms protect the bacterium from environmental stresses and increase its resistance to antimicrobial agents. In the human intestine, biofilm formation supports bacterial colonization and toxin secretion.

Cholera is an acute intestinal infection caused by V. cholerae. Symptoms include profuse watery diarrhea, vomiting, and severe dehydration. Without treatment, mortality rates can reach 50% due to dehydration; however, with oral rehydration therapy (ORT), this rate falls below 1%.

Cholera spreads via the fecal-oral route, typically through contaminated water or food. Poor sanitation is the primary driver of outbreaks. Historically, cholera has caused seven major pandemics. The seventh pandemic, which began in Indonesia in 1961 and is dominated by the El Tor biotype, continues to affect Africa, South Asia, and Latin America. According to World Health Organization (WHO) data, approximately 1.3 to 4 million cholera cases are reported annually, resulting in 21,000 to 143,000 deaths.

Feces from infected individuals contaminate water sources, accelerating disease transmission. Asymptomatic carriers contribute to the silent spread of the bacterium within populations. Environmental factors, particularly monsoon rains and floods, increase outbreak risk.

Cholera treatment primarily involves oral rehydration therapy (ORT) to replace lost fluids and electrolytes. In severe cases, intravenous fluid therapy may be required. Antibiotics are used to shorten disease duration and reduce bacterial load; common options include tetracycline, doxycycline, and azithromycin. However, multidrug resistance (MDR) in V. cholerae is increasing. For instance, strains carrying beta-lactamase genes (bla) exhibit resistance to penicillins and cephalosporins.

Cholera control involves ensuring access to clean water, improving sanitation infrastructure, and promoting hygiene education. Oral cholera vaccines (OCVs), such as Dukoral, Shanchol, and Euvichol, provide protection against O1 and O139 serogroups. WHO recommends mass vaccination campaigns in high-risk areas; for example, during the 2017 Yemen outbreak, over one million vaccine doses were administered.

Monitoring environmental reservoirs is crucial for outbreak prediction. Satellite imagery and sensors assess water temperature and plankton density to evaluate risk. Raising hygiene standards in the seafood industry reduces foodborne transmission